President Trump is expected to give a speech Tuesday about his plan to lower drug prices, and it has the industry on edge; despite the president telling crowds that the Affordable Care Act (ACA) is deceased, many pieces of it are alive and angering business groups; Idaho officials are still hoping to allow insurers to sell plans that don't comply with the ACA and are negotiating with federal officials over risk pools, risk adjustment programs, essential health benefits, and other issues.
President Trump is expected to give a speech Tuesday about his plan to lower drug prices, and it has the industry on edge, The Hill reported. Observers are wondering what will actually get said, since the president is known to ad lib; the speech could also be pushed back to later in the week. Other things to watch are if Trump will follow former President Obama on Medicare Part B drug pricing, if he will follow through on a campaign promise to allow Medicare to negotiate prices directly, and what will he say about pharmaceutical imports.Despite President Trump telling crowds that the Affordable Care Act (ACA) is deceased, many pieces of it are alive and angering business groups, The New York Times reported. And the Trump administration is even enforcing some of its provisions more aggressively than the previous administration, namely the employer mandate—the requirement that most companies offer health insurance to their workers or pay a penalty. The IRS has been sending penalty notices to more than 30,000 businesses around the country, the paper reported.Idaho officials are still hoping to allow insurers to sell plans that don't comply with the Affordable Care Act (ACA) and are negotiating with federal officials over risk pools, risk adjustment programs, essential health benefits, and other issues. The state says the action is needed to save Idaho's insurance exchange as premiums continue to rise and some healthy residents opt to go uninsured, the Associated Press reported.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More